AZIPRIC – 250
Fast-Acting Antibiotic for Effective Infection Control
Azipric-250 is a highly effective antibiotic formulation designed to fight a wide range of bacterial infections. Azithromycin belongs to the macrolide class of antibiotics and works by stopping the growth of bacteria responsible for infections. It is commonly prescribed for respiratory tract infections, throat infections, sinusitis, skin infections, ear infections, and certain bacterial sexually transmitted diseases.
Manufactured by Citric Labs, Azipric-250 is formulated under strict quality standards to ensure maximum efficacy, safety, and patient compliance. The product is highly suitable for pharma distributors and PCD franchise businesses looking for reliable antibiotic products with strong market demand.
Composition
- Azithromycin IP – 250 mg
Key Benefits
- Broad-spectrum antibacterial action
- Effective against respiratory and throat infections
- Helps in treating ear and skin infections
- Convenient once-daily dosage in many cases
- Better patient compliance due to shorter treatment duration
- Trusted quality from Citric Labs
Product Description
Azipric-250 contains Azithromycin 250 mg, a broad-spectrum macrolide antibiotic used for the treatment of bacterial infections affecting the respiratory tract, skin, throat, ear, and soft tissues. Manufactured with high-quality standards by Citric Labs
, it is widely trusted for PCD pharma franchise and third-party pharma distribution across India.
, it is widely trusted for PCD pharma franchise and third-party pharma distribution across India.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
